ARS Pharmaceuticals, Inc. — SC 13D/A Filings
6 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by ARS Pharmaceuticals, Inc. (SPRY), sorted by most recent first. Each row links to the full filing on EdgarLookup. ARS Pharmaceuticals, Inc. has filed 6 SC 13D/A documents with the SEC since 2016. To view all SEC filings by ARS Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFM14A
DRS
EFFECT
PREM14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | SC 13D/A | 0001193125-24-162824 | Jun 17, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-24-159314 | Jun 11, 2024 | — |
| SC 13D/A | SC 13D/A | 0001104659-24-041150 | Mar 29, 2024 | — |
| SC 13D/A | SC 13D/A | 0001104659-23-103530 | Sep 25, 2023 | — |
| SC 13D/A | SC 13D/A | 0001193125-23-227662 | Sep 1, 2023 | — |
| SC 13D/A | AMENDMENT NO. 1 | 0000947871-22-001216 | Nov 30, 2022 | — |